Delaware
(State or other jurisdiction of
incorporation)
|
1-08323
(Commission File Number)
|
06-1059331
(IRS Employer
Identification No.)
|
[ ]
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
[ ]
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
[ ]
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
[ ]
|
Pre-commencement communication pursuant to Rule 13e-49(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 9.01
|
Financial Statements and Exhibits.
|
(d)
|
Exhibits.
|
Exhibit No.
|
Description
|
Press release dated October 31, 2013.
|
Cigna Corporation | |
Date: October 31, 2013
|
By: /s/ Thomas A. McCarthy
|
|
Thomas A. McCarthy
|
Executive Vice President and
|
|
Chief Financial Officer
|
|
(Principal Financial Officer)
|
Number
|
Description
|
Method of Filing
|
Cigna Corporation
|
Furnished herewith.
|
|
press release dated
|
||
October 31, 2013
|
NEWS RELEASE | |
Contact: | Ted Detrick, Investor Relations – (215) 761-1414 |
Matt Asensio, Media Relations – (860) 226-2599 | |
°
|
Consolidated revenues increased 10% to $8.1 billion in the third quarter.
|
°
|
Adjusted income from operations1 was $536 million, or $1.89 per share, a 12% increase over third quarter 2012.
|
°
|
Shareholders’ net income1 was $553 million, or $1.95 per share.
|
°
|
Nine Months
|
||||||||||||||||
Three Months Ended
|
Ended
|
|||||||||||||||
September 30,
|
June 30,
|
September 30,
|
||||||||||||||
2013
|
2012
|
2013
|
2013
|
|||||||||||||
|
|
|
|
|||||||||||||
Total Revenues
|
$ | 8,066 | $ | 7,323 | $ | 7,980 | $ | 24,229 | ||||||||
Consolidated Earnings
|
||||||||||||||||
Adjusted income from operations1
|
$ | 536 | $ | 489 | $ | 512 | $ | 1,545 | ||||||||
Net realized investment gains, net of taxes
|
17 | 7 | 17 | 127 | ||||||||||||
GMIB results, net of taxes2
|
- | 32 | - | 25 | ||||||||||||
Special items, net of taxes4
|
- | (62 | ) | (24 | ) | (582 | ) | |||||||||
Shareholders' net income1
|
$ | 553 | $ | 466 | $ | 505 | $ | 1,115 | ||||||||
Adjusted income from operations1, per share
|
$ | 1.89 | $ | 1.69 | $ | 1.78 | $ | 5.39 | ||||||||
Shareholders' net income1, per share
|
$ | 1.95 | $ | 1.61 | $ | 1.76 | $ | 3.89 |
As of the Periods Ended
|
||||||||||
September 30,
|
June 30,
|
December 31,
|
||||||||
2013
|
2012
|
2013
|
2012
|
|||||||
Global Medical Customers
|
14,300
|
13,971
|
|
14,286
|
14,045
|
·
|
Cash and short term investments at the parent company were approximately $500 million at September 30, 2013 and approximately $700 million at December 31, 2012.
|
·
|
During the period August 1 through October 31, 2013, the Company repurchased5 approximately 6.4 million shares of stock for approximately $500 million.
|
·
|
Year to date, as of October 31, 2013, the Company has repurchased5 approximately 13.6 million shares of stock for approximately $1 billion.
|
Nine Months
|
||||||||||||||||
Three Months Ended
|
Ended
|
|||||||||||||||
September 30,
|
June 30,
|
September 30,
|
||||||||||||||
2013
|
2012
|
2013
|
2013
|
|||||||||||||
|
|
|
|
|||||||||||||
Premiums and Fees
|
$ | 5,699 | $ | 5,307 | $ | 5,687 | $ | 17,210 | ||||||||
Adjusted Income from Operations1
|
$ | 424 | $ | 419 | $ | 403 | $ | 1,254 | ||||||||
Adjusted Margin, After-Tax6
|
6.7 | % | 7.2 | % | 6.4 | % | 6.6 | % | ||||||||
As of the Periods Ended
|
||||||||||
September 30,
|
June 30,
|
December 31,
|
||||||||
Customers:
|
2013
|
2012
|
2013
|
2012
|
||||||
Commercial
|
13,812
|
13,530
|
13,804
|
13,596
|
||||||
Medicare and Medicaid
|
488
|
441
|
482
|
449
|
||||||
Medical
|
14,300
|
|
13,971
|
|
14,286
|
14,045
|
||||
Behavioral Care
|
22,564
|
|
21,544
|
|
22,386
|
21,750
|
||||
Dental
|
12,091
|
|
11,387
|
|
12,058
|
11,392
|
||||
Pharmacy
|
7,000
|
|
6,721
|
|
6,946
|
6,772
|
||||
Medicare Part D
|
1,195
|
|
1,265
|
|
1,200
|
1,264
|
·
|
Overall, Global Health Care results reflect continued growth in the Company’s targeted customer segments.
|
·
|
Third quarter premiums and fees increased approximately 7% relative to third quarter 2012, driven by customer growth, specialty contributions, and renewal rate increases.
|
·
|
Third quarter 2013 adjusted income from operations1 reflects sustained growth in medical and specialty businesses, continued effective medical cost management in our Commercial business, and improvement in the operating expense ratio, partially offset by an elevated Medicare Advantage care ratio.
|
·
|
Adjusted income from operations1 for third quarter 2013, second quarter 2013 and third quarter 2012 included favorable prior year reserve development on an after-tax basis of approximately $9 million, $20 million, and $6 million, respectively.
|
·
|
Global Health Care net medical claims payable7 was approximately $1.8 billion at September 30, 2013 and $1.6 billion at December 31, 2012.
|
Nine Months
|
||||||||||||||||
Three Months Ended
|
Ended
|
|||||||||||||||
September 30,
|
June 30,
|
September 30,
|
||||||||||||||
2013
|
2012
|
2013
|
2013
|
|||||||||||||
|
|
|
|
|||||||||||||
Premiums and Fees8
|
$ | 634 | $ | 493 | $ | 613 | $ | 1,851 | ||||||||
Adjusted Income from Operations1
|
$ | 39 | $ | 40 | $ | 49 | $ | 143 | ||||||||
Adjusted Margin, After-Tax6
|
5.9 | % | 7.7 | % | 7.6 | % | 7.3 | % |
As of the Periods Ended:
|
|
|||||||||||||||
September 30,
|
June 30,
|
December 31,
|
||||||||||||||
2013
|
2012
|
2013
|
2012
|
|||||||||||||
Policies8
|
11,823 | 9,438 | 11,798 | 11,436 |
·
|
Third quarter 2013 premiums and fees grew 29% relative to third quarter 2012, reflecting recent acquisitions of Great American Supplemental Benefits and our Cigna Finansbank joint venture in Turkey as well as customer growth, primarily in South Korea.
|
·
|
·
|
The quarter over quarter increase in policies as of September 30, 2013 reflects the recent acquisitions as well as organic business growth.
|
Nine Months
|
||||||||||||||||
Three Months Ended
|
Ended
|
|||||||||||||||
September 30,
|
June 30,
|
September 30,
|
||||||||||||||
2013
|
2012
|
2013
|
2013
|
|||||||||||||
|
|
|
|
|||||||||||||
Premiums and Fees
|
$ | 848 | $ | 775 | $ | 846 | $ | 2,552 | ||||||||
Adjusted Income from Operations1
|
$ | 92 | $ | 66 | $ | 104 | $ | 245 | ||||||||
Adjusted Margin, After-Tax6
|
9.9 | % | 7.8 | % | 11.2 | % | 8.8 | % |
·
|
Third quarter 2013 results benefited from premium and fee growth of 9% relative to third quarter 2012 due to growth in both disability and life businesses.
|
·
|
·
|
Third quarter 2013 and 2012 adjusted income from operations1 include favorable after-tax impacts related to reserve studies of $26 million and $5 million, respectively. Second quarter 2013 includes favorable after-tax impacts related to reserve studies of $27 million as well as $14 million related to an updated discount rate assumption.
|
Nine Months
|
||||||||||||||||
Three Months Ended
|
Ended
|
|||||||||||||||
September 30,
|
June 30,
|
September 30,
|
||||||||||||||
2013
|
2012
|
2013
|
2013
|
|||||||||||||
|
|
|
|
|||||||||||||
Run-off Reinsurance 2
|
$ | - | $ | (7 | ) | $ | (3 | ) | $ | (4 | ) | |||||
Other Operations
|
$ | 35 | $ | 22 | $ | 18 | $ | 74 | ||||||||
Corporate
|
$ | (54 | ) | $ | (51 | ) | $ | (59 | ) | $ | (167 | ) |
·
|
Third quarter 2013 Other Operations results include a $14 million after-tax benefit related to an IRS examination.
|
·
|
(Dollars in millions, except where noted and per share amounts)
|
|
|
Full-Year Ended
December 31, 2013
|
|
|
|
|
Global Health Care
|
$
|
1,575 to 1,625
|
|
Global Supplemental Benefits
|
185 to 195
|
||
Group Disability and Life
|
290 to 305
|
||
Ongoing Businesses
|
$
|
2,050 to 2,125
|
|
Corporate and other
|
$
|
(150) to (165)
|
|
Consolidated
|
$
|
1,900 to 1,960
|
|
Projected Consolidated Adjusted Income from Operations, per share1,3
|
$
|
6.70 to 6.90
|
|
Projected Global Medical Customer Growth
|
Approximately 1%
|
||
|
Cigna measures the financial results of its segments using segment earnings (loss), which is defined as shareholders’ net income (loss) before net realized investment results. Adjusted income (loss) from operations is defined as segment earnings (loss) excluding special items (which are identified and quantified in Note 4) and the results of Cigna's Guaranteed Minimum Income Benefits (GMIB) business. Adjusted income (loss) from operations is a measure of profitability used by Cigna’s management because it presents the underlying results of operations of Cigna’s businesses and permits analysis of trends in underlying revenue, expenses and shareholders’ net income. This measure is not determined in accordance with accounting principles generally accepted in the United States of America (GAAP) and should not be viewed as a substitute for the most directly comparable GAAP measures, which are segment earnings (loss) and shareholders’ net income; see Exhibit 2 for reconciliations of the non-GAAP measure to the most directly comparable GAAP measures.
|
|
Effective December 31, 2012, Cigna made changes to its external reporting segments to reflect the Company’s realignment of its businesses to leverage distribution and service delivery capabilities for the benefit of our global clients and customers. Prior period amounts have been presented on a comparable basis.
|
|
The GMIB business and Guaranteed Minimum Death Benefits business, also known as Variable Annuity Death Benefits (VADBe), are included in our Run-off Reinsurance operations. These businesses have been in run-off since 2000.
|
|
During the first quarter of 2013, Cigna entered into a definitive agreement with Berkshire Hathaway to exit the GMIB and VADBe businesses, effective February 4, 2013.
|
|
At this time, management is unable to identify or reasonably estimate future net realized investment results or special items; therefore, it is not possible to provide a forward-looking reconciliation of adjusted income from operations to shareholders’ net income. Special items for the remainder of 2013 may include amounts associated with litigation, guaranty fund assessments and cost reduction initiatives.
|
|
Special items included in shareholders’ net income and segment earnings (loss), but excluded from adjusted income (loss) from operations, and the calculation of adjusted margin include:
|
·
|
After-tax loss of $24 million related to the pharmacy benefits arrangement with Catamaran.
|
·
|
After-tax loss of $507 million related to the exit of the Run-off Reinsurance businesses.
|
·
|
After-tax loss of $51 million related to a regulatory matter within the Disability business.
|
·
|
After-tax loss of $50 million related to a realignment and efficiency plan
|
·
|
After-tax loss of $12 million related to transaction costs for the 2012 acquisition of HealthSpring.
|
|
Share repurchases may from time to time be made pursuant to written trading plans under Rule 10b5-1, which permits shares to be repurchased when Cigna might otherwise be precluded from doing so under insider trading laws or because of self-employed trading blackout periods.
|
|
Adjusted margin, after-tax, is calculated by dividing segment earnings (loss) excluding special items by segment revenues. For the three and nine months ending September 30, 2013, segment margins (defined as segment earnings (loss) divided by segment revenues) were 6.7% and 6.5% for Global Health Care, respectively, 5.9% and 7.3% for Global Supplemental Benefits, respectively, and 9.9% and 7.0% for Group Disability and Life, respectively. For the three months ended June 30, 2013 and September 30, 2012, segment margins were 6.1% and 6.5% for Global Health Care, respectively, 7.6% and 6.5% for Global Supplemental Benefits, respectively, and 11.2% and 7.5% for Group Disability and Life, respectively.
|
Global Health Care medical claims payable are presented net of reinsurance and other recoverables. The gross Global Health Care medical claims payable balance was $1,962 million as of September 30, 2013 and $1,856 million as of December 31, 2012.
|
Cigna owns a 50% noncontrolling interest in its China joint venture. Cigna's 50% share of the joint venture’s earnings is reported in Other Revenues using the equity method of accounting under GAAP. As such, the premiums and fees and policy counts from the China joint venture are not included in the financial results table for the Global Supplemental Benefits segment presented in the earnings release.
|
|
1.
|
health care reform legislation, as well as additional changes in state or federal regulation, that could, among other items, affect the way the Company does business, increase costs, limit the ability to effectively estimate, price for and manage medical costs, and affect the Company’s products, services, market segments, technology and processes;
|
|
2.
|
adverse changes in state, federal and international laws and regulations, including increased medical, administrative, technology or other costs resulting from new legislative and regulatory requirements imposed on the Company’s businesses;
|
|
3.
|
risks associated with pending and potential state and federal class action lawsuits, disputes regarding reinsurance arrangements, other litigation and regulatory actions challenging the Company’s businesses, including disputes related to payments to health care professionals, government investigations and proceedings, tax audits and related litigation, and regulatory market conduct and other reviews, audits and investigations, including the possibility that the Cigna-HealthSpring business may be adversely affected by potential changes in risk adjustment data validation audit and payment adjustment methodology;
|
|
4.
|
challenges and risks associated with implementing improvement initiatives and strategic actions in the ongoing operations of the businesses, including those related to: (i) growth in targeted geographies, product lines, buying segments and distribution channels, (ii) offering products that meet emerging market needs, (iii) strengthening underwriting and pricing effectiveness, (iv) strengthening medical cost results and a growing medical customer base, (v) delivering quality service to members and health care professionals using effective technology solutions, and (vi) lowering administrative costs;
|
|
5.
|
the unique political, legal, operational, regulatory and other challenges associated with expanding our business globally;
|
|
6.
|
challenges and risks associated with the successful management of the Company’s outsourcing projects or key vendors;
|
|
7.
|
the ability of the Company to execute its growth plans by successfully leveraging capabilities and integrating acquired businesses, including the Cigna-HealthSpring business by, among other things, operating Medicare Advantage plans and Cigna-HealthSpring’s prescription drug plan, retaining and growing the customer base, realizing revenue, expense and other synergies, renewing contracts on competitive terms or maintaining performance under Medicare contracts, successfully leveraging the information technology platform of the acquired businesses, and retaining key personnel;
|
|
8.
|
risks associated with security or interruption of information systems, that could, among other things, cause operational disruption;
|
|
9.
|
risks associated with the Company’s information technology strategy, including that the failure to make effective investments or execute improvements may impede the Company’s ability to deliver services efficiently;
|
|
10.
|
the failure to maintain effective prevention, detection and control systems for regulatory compliance and detection of fraud and abuse;
|
|
11.
|
risks associated with the pharmacy benefits management agreement with Catamaran Corporation, including without limitation, those related to the ability to transition and implement successfully the agreement in a timely, cost-efficient manner without an adverse impact on service to clients and customers, and the failure to achieve projected operating efficiencies, estimated earnings per share accretion and estimated financial contribution to the Company’s results;
|
|
12.
|
risks associated with the Company’s mail order pharmacy business that, among other things, includes any potential operational deficiencies or service issues as well as loss or suspension of state pharmacy licenses;
|
|
13.
|
liability associated with the Company’s operations of onsite clinics and medical facilities, including the health care centers operated by the Cigna-HealthSpring business;
|
|
14.
|
heightened competition, particularly price competition, that could reduce product margins and constrain growth in the Company’s businesses, primarily the Global Health Care business;
|
|
15.
|
significant stock market declines, that could, among other things, impact the Company’s pension plans in future periods as well as the recognition of additional pension obligations;
|
|
16.
|
significant changes in market interest rates or sustained deterioration in the commercial real estate markets that could reduce the value of the Company’s investment assets;
|
|
17.
|
downgrades in the financial strength ratings of the Company’s insurance subsidiaries, that could, among other things, adversely affect new sales and retention of current business or limit the subsidiaries’ ability to dividend capital to the parent company, resulting in changes in statutory reserve or capital requirements or other financial constraints;
|
|
18.
|
significant deterioration in global market economic conditions and market volatility, that could have an adverse effect on the Company’s investments, liquidity and access to capital markets;
|
|
19.
|
unfavorable developments in economic conditions, that could, among other things, have an adverse effect on the impact on the businesses of our customers (including the amount and type of health care services provided to their workforce, loss in workforce and ability to pay their obligations), the businesses of hospitals and other providers (including increased medical costs) or state and federal budgets for programs, such as Medicare or social security, resulting in a negative impact to the Company’s revenues or results of operations;
|
|
20.
|
risks associated with the Company’s reinsurance arrangements for the run-off retirement benefits, life insurance and annuity business, variable annuity death benefits and guaranteed minimum income benefits businesses, including but not limited to, failure by the reinsurer to meet its reinsurance obligations or that the reinsurance does not otherwise provide adequate protection; or
|
|
21.
|
potential public health epidemics, pandemics, natural disasters and bio-terrorist activity, that could, among other things, cause the Company’s covered medical and disability expenses, pharmacy costs and mortality experience to rise significantly, and cause operational disruption, depending on the severity of the event and number of individuals affected.
|
CIGNA CORPORATION
|
||||||||||||||||
COMPARATIVE SUMMARY OF FINANCIAL RESULTS (unaudited)
|
||||||||||||||||
(Dollars in millions, except per share amounts)
|
||||||||||||||||
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||
September 30,
|
September 30,
|
|||||||||||||||
2013
|
2012
|
2013
|
2012
|
|||||||||||||
REVENUES
|
||||||||||||||||
Premiums and fees
|
$ | 7,206 | $ | 6,602 | $ | 21,692 | $ | 19,360 | ||||||||
Net investment income
|
297 | 283 | 873 | 854 | ||||||||||||
Mail order pharmacy revenues
|
471 | 401 | 1,333 | 1,189 | ||||||||||||
Other revenues
|
65 | 68 | 178 | 182 | ||||||||||||
Total operating revenues
|
8,039 | 7,354 | 24,076 | 21,585 | ||||||||||||
Run-off Reinsurance hedge loss (1)
|
- | (42 | ) | (39 | ) | (106 | ) | |||||||||
Net realized investment gains
|
27 | 11 | 192 | 20 | ||||||||||||
Total
|
$ | 8,066 | $ | 7,323 | $ | 24,229 | $ | 21,499 | ||||||||
ADJUSTED INCOME (LOSS) FROM OPERATIONS (2)
|
||||||||||||||||
Global Health Care
|
$ | 424 | $ | 419 | $ | 1,254 | $ | 1,083 | ||||||||
Global Supplemental Benefits
|
39 | 40 | 143 | 110 | ||||||||||||
Group Disability and Life
|
92 | 66 | 245 | 225 | ||||||||||||
Run-off Reinsurance
|
- | (7 | ) | (4 | ) | (29 | ) | |||||||||
Other Operations
|
35 | 22 | 74 | 63 | ||||||||||||
Corporate
|
(54 | ) | (51 | ) | (167 | ) | (170 | ) | ||||||||
Total
|
$ | 536 | $ | 489 | $ | 1,545 | $ | 1,282 | ||||||||
SHAREHOLDERS' NET INCOME
|
||||||||||||||||
Segment Earnings (Loss)
|
||||||||||||||||
$ | 424 | $ | 377 | $ | 1,230 | $ | 1,021 | |||||||||
Global Supplemental Benefits
|
39 | 34 | 143 | 104 | ||||||||||||
Group Disability and Life (5)
|
92 | 64 | 194 | 223 | ||||||||||||
Run-off Reinsurance (4)
|
- | 25 | (486 | ) | (7 | ) | ||||||||||
Other Operations
|
35 | 22 | 74 | 63 | ||||||||||||
Corporate (6)
|
(54 | ) | (63 | ) | (167 | ) | (203 | ) | ||||||||
Total
|
536 | 459 | 988 | 1,201 | ||||||||||||
Net realized investment gain (loss), net of taxes
|
17 | 7 | 127 | 16 | ||||||||||||
Shareholders' net income
|
$ | 553 | $ | 466 | $ | 1,115 | $ | 1,217 | ||||||||
DILUTED EARNINGS PER SHARE:
|
||||||||||||||||
Adjusted income from operations (2)
|
$ | 1.89 | $ | 1.69 | $ | 5.39 | $ | 4.42 | ||||||||
Results of guaranteed minimum income benefits business, after-tax
|
- | 0.11 | 0.09 | 0.07 | ||||||||||||
Net realized investment gain (loss), net of taxes
|
0.06 | 0.02 | 0.44 | 0.06 | ||||||||||||
- | (0.21 | ) | (2.03 | ) | (0.35 | ) | ||||||||||
Shareholders' net income
|
$ | 1.95 | $ | 1.61 | $ | 3.89 | $ | 4.20 | ||||||||
Weighted average shares (in thousands)
|
283,563 | 289,875 | 286,615 | 289,807 | ||||||||||||
SHAREHOLDERS' EQUITY at September 30
|
$ | 9,874 | $ | 9,530 | ||||||||||||
SHAREHOLDERS' EQUITY PER SHARE at September 30
|
$ | 35.64 | $ | 33.24 | ||||||||||||
|
||||||||||||||||
Effective December 31, 2012, Cigna changed its external reporting segments. The primary change was that the two businesses that comprised the former International segment (international health care and supplemental health, life and accident) are now reported as follows: 1) substantially all of the international health care business (comprised primarily of the global health benefits business) is now combined with the former Health Care segment and renamed Global Health Care; and 2) the supplemental health, life and accident business is now a separate reporting segment named Global Supplemental Benefits. In addition, certain disability and life products previously reported in the former Health Care segment are now reported in the Group Disability and Life segment. Prior period segment information has been conformed to the current reporting segments. Please refer to Cigna's Form 8-K filed on January 24, 2013 for additional information.
|
||||||||||||||||
|
||||||||||||||||
presented in accordance with accounting principles generally accepted in the United States of America.
|
||||||||||||||||
|
||||||||||||||||
|
||||||||||||||||
|
||||||||||||||||
|
||||||||||||||||
CIGNA CORPORATION
|
||||||||||||||||||||||||||||||||||||||||||||||||
SUPPLEMENTAL FINANCIAL INFORMATION (unaudited)
|
||||||||||||||||||||||||||||||||||||||||||||||||
RECONCILIATION OF ADJUSTED INCOME (LOSS) FROM OPERATIONS TO SHAREHOLDERS' NET INCOME
|
||||||||||||||||||||||||||||||||||||||||||||||||
(Dollars in millions, except per share amounts)
|
||||||||||||||||||||||||||||||||||||||||||||||||
Diluted
|
Global
|
Global Supplemental
|
||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share
|
Consolidated
|
Health Care
|
Benefits
|
|||||||||||||||||||||||||||||||||||||||||||||
Three Months Ended,
|
3Q13 | 3Q12 | 2Q13 | 3Q13 | 3Q12 | 2Q13 | 3Q13 | 3Q12 | 2Q13 | 3Q13 | 3Q12 | 2Q13 | ||||||||||||||||||||||||||||||||||||
Adjusted income (loss) from operations (1)
|
$ | 1.89 | $ | 1.69 | $ | 1.78 | $ | 536 | $ | 489 | $ | 512 | $ | 424 | $ | 419 | $ | 403 | $ | 39 | $ | 40 | $ | 49 | ||||||||||||||||||||||||
Results of guaranteed minimum income benefits business (2)
|
- | 0.11 | - | - | 32 | - | - | - | - | - | - | - | ||||||||||||||||||||||||||||||||||||
Special item(s), after-tax:
|
||||||||||||||||||||||||||||||||||||||||||||||||
Charge for realignment and efficiency plan (8)
|
- | (0.17 | ) | - | - | (50 | ) | - | - | (42 | ) | - | - | (6 | ) | - | ||||||||||||||||||||||||||||||||
Cost associated with acquisitions (6)
|
- | (0.04 | ) | - | - | (12 | ) | - | - | - | - | - | - | - | ||||||||||||||||||||||||||||||||||
Cost associated with PBM services agreement (3)
|
- | - | (0.08 | ) | - | - | (24 | ) | - | - | (24 | ) | - | - | - | |||||||||||||||||||||||||||||||||
Segment earnings (loss)
|
1.89 | 1.59 | 1.70 | 536 | 459 | 488 | $ | 424 | $ | 377 | $ | 379 | $ | 39 | $ | 34 | $ | 49 | ||||||||||||||||||||||||||||||
Net realized investment gains, net of taxes
|
0.06 | 0.02 | 0.06 | 17 | 7 | 17 | ||||||||||||||||||||||||||||||||||||||||||
Shareholders' net income
|
$ | 1.95 | $ | 1.61 | $ | 1.76 | $ | 553 | $ | 466 | $ | 505 |
Diluted
|
Global
|
Global Supplemental
|
||||||||||||||||||||||||||||||
Earnings Per Share
|
Consolidated
|
Health Care
|
Benefits
|
|||||||||||||||||||||||||||||
Nine Months Ended September 30,
|
2013 | 2012 | 2013 | 2012 | 2013 | 2012 | 2013 | 2012 | ||||||||||||||||||||||||
Adjusted income (loss) from operations (1)
|
$ | 5.39 | $ | 4.42 | $ | 1,545 | 1,282 | $ | 1,254 | $ | 1,083 | $ | 143 | $ | 110 | |||||||||||||||||
Results of guaranteed minimum income benefits business (2)
|
0.09 | 0.07 | 25 | 22 | - | - | - | - | ||||||||||||||||||||||||
Special item(s), after-tax:
|
||||||||||||||||||||||||||||||||
Cost associated with PBM services agreement (3)
|
(0.08 | ) | - | (24 | ) | - | (24 | ) | - | - | - | |||||||||||||||||||||
Charge related to reinsurance transaction (4)
|
(1.77 | ) | - | (507 | ) | - | - | - | - | - | ||||||||||||||||||||||
Charge for disability claims regulatory matter (5)
|
(0.18 | ) | - | (51 | ) | - | - | - | - | - | ||||||||||||||||||||||
Charge for realignment and efficiency plan (8)
|
(0.17 | ) | - | (50 | ) | - | (42 | ) | - | (6 | ) | |||||||||||||||||||||
Cost associated with acquisitions (6)
|
- | (0.14 | ) | - | (40 | ) | - | (7 | ) | - | - | |||||||||||||||||||||
Litigation matters (7)
|
- | (0.04 | ) | - | (13 | ) | - | (13 | ) | - | - | |||||||||||||||||||||
Segment earnings (loss)
|
3.45 | 4.14 | 988 | 1,201 | $ | 1,230 | $ | 1,021 | $ | 143 | $ | 104 | ||||||||||||||||||||
Net realized investment gains, net of taxes
|
0.44 | 0.06 | 127 | 16 | ||||||||||||||||||||||||||||
Shareholders' net income
|
$ | 3.89 | $ | 4.20 | $ | 1,115 | 1,217 |
Group Disability
|
Run-off
|
Other
|
||||||||||||||||||||||||||||||||||||||||||||||
and Life
|
Reinsurance
|
Operations
|
Corporate
|
|||||||||||||||||||||||||||||||||||||||||||||
Three Months Ended,
|
3Q13 | 3Q12 | 2Q13 | 3Q13 | 3Q12 | 2Q13 | 3Q13 | 3Q12 | 2Q13 | 3Q13 | 3Q12 | 2Q13 | ||||||||||||||||||||||||||||||||||||
Adjusted income (loss) from operations (1)
|
$ | 92 | $ | 66 | $ | 104 | $ | - | $ | (7 | ) | $ | (3 | ) | $ | 35 | $ | 22 | $ | 18 | $ | (54 | ) | $ | (51 | ) | $ | (59 | ) | |||||||||||||||||||
Results of guaranteed minimum income benefits business (2)
|
- | - | - | - | 32 | - | - | - | - | - | - | - | ||||||||||||||||||||||||||||||||||||
Special item(s), after-tax:
|
||||||||||||||||||||||||||||||||||||||||||||||||
Charge for realignment and efficiency plan (8)
|
- | (2 | ) | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||||
Cost associated with acquisitions (6)
|
- | - | - | - | - | - | - | - | - | - | (12 | ) | - | |||||||||||||||||||||||||||||||||||
Cost associated with PBM services agreement (3)
|
- | - | - | - | - | - | - | - | - | - | - | - | ||||||||||||||||||||||||||||||||||||
Segment earnings (loss)
|
$ | 92 | $ | 64 | $ | 104 | $ | - | $ | 25 | $ | (3 | ) | $ | 35 | $ | 22 | $ | 18 | $ | (54 | ) | $ | (63 | ) | $ | (59 | ) | ||||||||||||||||||||
Net realized investment gains, net of taxes
|
||||||||||||||||||||||||||||||||||||||||||||||||
Group Disability
|
Run-off
|
Other
|
||||||||||||||||||||||||||||||
and Life
|
Reinsurance
|
Operations
|
Corporate
|
|||||||||||||||||||||||||||||
Nine Months Ended September 30,
|
2013 | 2012 | 2013 | 2012 | 2013 | 2012 | 2013 | 2012 | ||||||||||||||||||||||||
Adjusted income (loss) from operations (1)
|
$ | 245 | $ | 225 | $ | (4 | ) | $ | (29 | ) | $ | 74 | $ | 63 | $ | (167 | ) | $ | (170 | ) | ||||||||||||
Results of guaranteed minimum income benefits business (2)
|
- | - | 25 | 22 | - | - | - | - | ||||||||||||||||||||||||
Special item(s), after-tax:
|
||||||||||||||||||||||||||||||||
Cost associated with PBM services agreement (3)
|
- | - | - | - | - | - | - | - | ||||||||||||||||||||||||
Charge related to reinsurance transaction (4)
|
- | - | (507 | ) | - | - | - | - | - | |||||||||||||||||||||||
Charge for disability claims regulatory matter (5)
|
(51 | ) | - | - | - | - | - | - | - | |||||||||||||||||||||||
Charge for realignment and efficiency plan (8) | - | (2 | ) | - | - | - | - | - | - | |||||||||||||||||||||||
Cost associated with acquisitions (6)
|
- | - | - | - | - | - | - | (33 | ) | |||||||||||||||||||||||
Litigation matters (7)
|
- | - | - | - | - | - | - | - | ||||||||||||||||||||||||
Segment earnings (loss)
|
$ | 194 | $ | 223 | $ | (486 | ) | $ | (7 | ) | $ | 74 | $ | 63 | $ | (167 | ) | $ | (203 | ) | ||||||||||||
|
||||||||||||||||||||||||||||||||
- three months and nine months ended September 30, 2013 were $0 million and gains of $39 million, respectively;
- three months and nine months ended September 30, 2012 were gains of $50 million and $34 million, respectively; and
- three months ended June 30, 2013 were $0 million.
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
^5?ZD*E8&^0(A#&)$3L-(X1Z-N+\%@..M>
ML8ZM0I,*)FL%KZ1EZV:9!EB;"DO(PJI$'/&L42RMG6.-9FQNB;,K&K*V)[F/
M?&V3Q[TC>^.-SF(OM I4#(!)&/
M1LC'C643FR-;(BH]K53,7'->U3J7DE7NU:]Q!_O(M(5827^R8&UKI9&2L'MJ6R@#N*DE\4K1K($6=T
\H[7QE:R%G6&T1_%5UEWT7Z8VTO&F3RK_`#!J>J0FP[O*7+\X/\_E
MXAXU5RGPUI7,%/%T]P3DB_!6W&XVQC+YT;%8[XUPM?$K=7=#(J5_A]=OA*^X
M>/D?E27K_0][_&&M%)PO`*F!9/8MB?LS&I0VM]RI\JQU